|
1
|
A novel gene containing a trinucleotide
repeat that is expanded and unstable on Huntington's disease
chromosomes. The Huntington's Disease Collaborative Research Group.
Cell. 72:971–983. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sinha M, Mukhopadhyay S and Bhattacharyya
NP: Mechanism(s) of alteration of Micro RNA expressions in
huntington's disease and their possible contributions to the
observed cellular and molecular dysfunctions in the disease.
Neuromolecular Med. 14:221–243. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Azambuja MJ, Haddad MS, Radanovic M,
Barbosa ER and Mansur LL: Semantic, phonologic, and verb fluency in
Huntington's disease. Dement Neuropsychol. 1:381–385. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tabrizi SJ, Langbehn DR, Leavitt BR, Roos
RA, Durr A, Craufurd D, Kennard C, Hicks SL, Fox NC, Scahill RI, et
al: Biological and clinical manifestations of Huntington's disease
in the longitudinal TRACK-HD study: Cross-sectional analysis of
baseline data. Lancet Neurol. 8:791–801. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Orford K, Crockett C, Jensen JP, Weissman
AM and Byers SW: Serine phosphorylation-regulated ubiquitination
and degradation of beta-catenin. J Biol Chem. 272:24735–24738.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Seredenina T and Luthi-Carter R: What have
we learned from gene expression profiles in Huntington's disease?
Neurobiol Dis. 45:83–98. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cong SY, Pepers BA, Evert BO, Rubinsztein
DC, Roos RA, van Ommen GJ and Dorsman JC: Mutant huntingtin
represses CBP, but not p300, by binding and protein degradation.
Mol Cell Neurosci. 30:12–23. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bae BI, Xu H, Igarashi S, Fujimuro M,
Agrawal N, Taya Y, Hayward SD, Moran TH, Montell C, Ross CA, et al:
p53 mediates cellular dysfunction and behavioral abnormalities in
Huntington's disease. Neuron. 47:29–41. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dunah AW, Jeong H, Griffin A, Kim YM,
Standaert DG, Hersch SM, Mouradian MM, Young AB, Tanese N and
Krainc D: Sp1 and TAFII130 transcriptional activity disrupted in
early Huntington's disease. Science. 296:2238–2243. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li JL, Hayden M, Almqvist EW, Brinkman RR,
Durr A, Dodé C, Morrison PJ, Suchowersky O, Ross CA, Margolis RL,
et al: A genome scan for modifiers of age at onset in Huntington's
disease: The HD MAPS study. Am J Hum Genet. 73:682–687. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sinha M, Ghose J and Bhattarcharyya NP:
Micro RNA-214,-150,-146a and-125b target Huntingtin gene. RNA Biol.
8:1005–1021. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Santiago JA and Potashkin JA: A network
approach to clinical intervention in neurodegenerative diseases.
Trends Mol Med. 20:694–703. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nguyen TP, Caberlotto L, Morine MJ and
Priami C: Network analysis of neurodegenerative disease highlights
a role of Toll-like receptor signaling. Biomed Res Int.
2014:6865052014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hofmann-Apitius M, Ball G, Gebel S,
Bagewadi S, de Bono B, Schneider R, Page M, Kodamullil AT, Younesi
E, Ebeling C, et al: Bioinformatics mining and modeling methods for
the identification of disease mechanisms in neurodegenerative
disorders. Int J Mol Sci. 16:29179–29206. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sadri-Vakili G, Bouzou B, Benn CL, Kim MO,
Chawla P, Overland RP, Glajch KE, Xia E, Qiu Z, Hersch SM, et al:
Histones associated with downregulated genes are hypo-acetylated in
Huntington's disease models. Hum Mol Genet. 16:1293–1306. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Smyth GK: Limma: Linear models for
microarray data. 2005.
|
|
17
|
Guo W and Rao MB: On control of the false
discovery rate under no assumption of dependency. J Statistical
Plan Inference. 138:3176–3188. 2008. View Article : Google Scholar
|
|
18
|
Huang Da W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protocols. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Carbon S, Ireland A, Mungall CJ, Shu S,
Marshall B and Lewis S; AmiGO Hub, ; Web Presence Working Group, :
AmiGO: Online access to ontology and annotation data.
Bioinformatics. 25:288–289. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kanehisa M, Araki M, Goto S, Hattori M,
Hirakawa M, Itoh M, Katayama T, Kawashima S, Okuda S, Tokimatsu T
and Yamanishi Y: KEGG for linking genomes to life and the
environment. Nucleic Acids Res. 36(Database Issue): D480–D484.
2008.PubMed/NCBI
|
|
21
|
Szklarczyk D, Franceschini A, Kuhn M,
Simonovic M, Roth A, Minguez P, Doerks T, Stark M, Muller J, Bork
P, et al: The STRING database in 2011: Functional interaction
networks of proteins, globally integrated and scored. Nucleic Acids
Res. 39(Database Issue): D561–D568. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Smoot ME, Ono K, Ruscheinski J, Wang PL
and Ideker T: Cytoscape 2.8: New features for data integration and
network visualization. Bioinformatics. 27:431–432. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bader GD and Hogue CW: An automated method
for finding molecular complexes in large protein interaction
networks. BMC Bioinformatics. 4:22003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wingender E: The TRANSFAC project as an
example of framework technology that supports the analysis of
genomic regulation. Brief Bioinform. 9:326–332. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang JF, Chen Y, Lin GS, Zhang JD, Tang
WL, Huang JH, Chen JS, Wang XF and Lin ZX: High IFIT1 expression
predicts improved clinical outcome, and IFIT1 along with MGMT more
accurately predicts prognosis in newly diagnosed glioblastoma. Hum
Pathol. 52:136–144. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Squitieri F, Cannella M, Sgarbi G,
Maglione V, Falleni A, Lenzi P, Baracca A, Cislaghi G, Saft C,
Ragona G, et al: Severe ultrastructural mitochondrial changes in
lymphoblasts homozygous for Huntington disease mutation. Mech
Ageing Dev. 127:217–220. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bayram-Weston Z, Stone TC, Giles P,
Elliston L, Janghra N, Higgs GV, Holmans PA, Dunnett SB, Brooks SP
and Jones L: Similar striatal gene expression profiles in the
striatum of the YAC128 and HdhQ150 mouse models of Huntington's
disease are not reflected in mutant Huntingtin inclusion
prevalence. BMC Genomics. 16:10792015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jordanovski D, Herwartz C, Pawlowski A,
Taute S, Frommolt P and Steger G: The hypoxia-inducible
transcription factor ZNF395 is controlled by IκB kinase-signaling
and activates genes involved in the innate immune response and
cancer. PLoS One. 8:e749112013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ellrichmann G, Reick C, Saft C and Linker
RA: The role of the immune system in Huntington's disease. Clin Dev
Immunol. 2013:5412592013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhu J, Zhang Y, Ghosh A, Cuevas RA, Forero
A, Dhar J, Ibsen MS, Schmid-Burgk JL, Schmidt T, Ganapathiraju MK,
et al: Antiviral activity of human OASL protein is mediated by
enhancing signaling of the RIG-I RNA sensor. Immunity. 40:936–948.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kwan W, Träger U, Davalos D, Chou A,
Bouchard J, Andre R, Miller A, Weiss A, Giorgini F, Cheah C, et al:
Mutant huntingtin impairs immune cell migration in Huntington
disease. J Clin Invest. 122:4737–4747. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
McDermott JE, Archuleta M, Thrall BD,
Adkins JN and Waters KM: Controlling the response: Predictive
modeling of a highly central, pathogen-targeted core response
module in macrophage activation. PLoS One. 6:e146732011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
MacNair L, Xiao S, Miletic D, Ghani M,
Julien JP, Keith J, Zinman L, Rogaeva E and Robertson J: MTHFSD and
DDX58 are novel RNA-binding proteins abnormally regulated in
amyotrophic lateral sclerosis. Brain. 139:86–100. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tauffenberger A, Chitramuthu BP, Bateman
A, Bennett HP and Parker JA: Reduction of polyglutamine toxicity by
TDP-43, FUS and progranulin in Huntington's disease models. Hum Mol
Genet. 22:782–794. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
de Rivero Vaccari JP, Brand FJ III,
Sedaghat C, Mash DC, Dietrich WD and Keane RW: RIG-1 receptor
expression in the pathology of Alzheimer's disease. J Neuroinflam.
11:672014. View Article : Google Scholar
|
|
37
|
Oudshoorn D, van Boheemen S,
Sánchez-Aparicio MT, Rajsbaum R, Garcia-Sastre A and Versteeg GA:
HERC6 is the main E3 ligase for global ISG15 conjugation in mouse
cells. PLoS One. 7:e298702012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang RG, Kaul M and Zhang DX:
Interferon-stimulated gene 15 as a general marker for acute and
chronic neuronal injuries. Sheng Li Xue Bao. 64:577–583.
2012.PubMed/NCBI
|
|
39
|
Desai SD, Reed RE, Babu S and Lorio EA:
ISG15 deregulates autophagy in genotoxin-treated ataxia
telangiectasia cells. J Biol Chem. 288:2388–2402. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Nicolas CS, Amici M, Bortolotto ZA,
Doherty A, Csaba Z, Fafouri A, Dournaud P, Gressens P, Collingridge
GL and Peineau S: The role of JAK-STAT signaling within the CNS.
JAKSTAT. 2:e229252013.PubMed/NCBI
|
|
41
|
Fu MH, Li CL, Lin HL, Tsai SJ, Lai YY,
Chang YF, Cheng PH, Chen CM and Yang SH: The potential regulatory
mechanisms of miR-196a in Huntington's disease through
bioinformatic analyses. PLoS One. 10:e01376372015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ruvkun G: The perfect storm of tiny RNAs.
Nat Med. 14:1041–1045. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Krichevsky AM, King KS, Donahue CP,
Khrapko K and Kosik KS: A microRNA array reveals extensive
regulation of microRNAs during brain development. RNA. 9:1–1281.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Berezikov E, Thuemmler F, van Laake LW,
Kondova I, Bontrop R, Cuppen E and Plasterk RH: Diversity of
microRNAs in human and chimpanzee brain. Nat Genet. 38:1375–1377.
2006. View
Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kozlowska E, Krzyzosiak WJ and Koscianska
E: Regulation of huntingtin gene expression by
miRNA-137,-214,-148a, and their respective isomiRs. Int J Mol Sci.
14:16999–17016. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Sinha M, Ghose J, Das E and Bhattarcharyya
NP: Altered microRNAs in STHdh(Q111)/Hdh(Q111) cells: miR-146a
targets TBP. Biochem Biophys Res Commun. 396:742–747. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Ban JJ, Chung JY, Lee M, Im W and Kim M:
MicroRNA-27a reduces mutant hutingtin aggregation in an in vitro
model of Huntington's disease. Biochem Biophys Res Commun.
488:316–321. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Sheng J, Luo C, Jiang Y, Hinds PW, Xu Z
and Hu GF: Transcription of angiogenin and ribonuclease 4 is
regulated by RNA polymerase III elements and a CCCTC binding factor
(CTCF)-dependent intragenic chromatin loop. J Biol Chem.
289:12520–12534. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Li S, Sheng J, Hu JK, Yu W, Kishikawa H,
Hu MG, Shima K, Wu D, Xu Z, Xin W, et al: Ribonuclease 4 protects
neuron degeneration by promoting angiogenesis, neurogenesis, and
neuronal survival under stress. Angiogenesis. 16:387–404. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Fay A, Misulovin Z, Li J, Schaaf CA, Gause
M, Gilmour DS and Dorsett D: Cohesin selectively binds and
regulates genes with paused RNA polymerase. Curr Biol.
21:1624–1634. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Li S, Yu W and Hu GF: Angiogenin inhibits
nuclear translocation of apoptosis inducing factor in a
Bcl-2-dependent manner. J Cell Physiol. 227:1639–1644. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Johnson R and Buckley NJ: Gene
dysregulation in Huntington's disease: REST, microRNAs and beyond.
Neuromolecular Med. 11:183–199. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Das E, Jana NR and Bhattacharyya NP:
MicroRNA-124 targets CCNA2 and regulates cell cycle in
STHdh(Q111)/Hdh(Q111) cells. Biochem Biophys Res Commun.
437:217–224. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Ben Haim L, Ceyzériat K, Carrillo-de
Sauvage MA, Aubry F, Auregan G, Guillermier M, Ruiz M, Petit F,
Houitte D, Faivre E, et al: The JAK/STAT3 pathway is a common
inducer of astrocyte reactivity in Alzheimer's and Huntington's
diseases. J Neurosci. 35:2817–2829. 2015. View Article : Google Scholar : PubMed/NCBI
|
